Your company, Enzyme, Inc., manufactures biological and chemical agents that have potential military uses. You understand that Congress is considering the contentious issue of how to revamp the entire export control regimen. Prepare a letter to your state’s senators articulating your company’s position about decontrol. Do you think your company should take an active role in lobbying for a new law? What are the risks associated with such a position? Will you discuss these issues with your board of directors?